These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1509190)

  • 41. Long-term effects of almitrine bismesylate in COPD patients with chronic hypoxaemia.
    Sans-Torres J; Domingo C; Morón A; Rué M; Marín A
    Respir Med; 2003 Jun; 97(6):599-605. PubMed ID: 12814142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease.
    Watanabe S; Kanner RE; Cutillo AG; Menlove RL; Bachand RT; Szalkowski MB; Renzetti AD
    Am Rev Respir Dis; 1989 Nov; 140(5):1269-73. PubMed ID: 2683905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A one-year double-blind placebo-controlled study of the efficacy and safety of almitrine bismesylate in hypoxic COLD patients. Monitoring progress status on 490 patients entered into the VIMS study before January 1st, 1984.
    Ansquer JC
    Eur J Respir Dis Suppl; 1986; 146():703-12. PubMed ID: 3536563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is the mode of action of almitrine bismesylate dose dependent?
    Le Merre C; Ansquer JC; Clark MJ; Zouari N; Préfaut C
    Respiration; 1989; 56(3-4):212-9. PubMed ID: 2635350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The predictive parameters in the response to almitrine treatment].
    González Ruiz JM; Villamor J; Pino JM; Muñoz J; Lobato SD; Prados C
    Arch Bronconeumol; 1994 Mar; 30(3):141-4. PubMed ID: 8186906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral nerve function in patients with chronic bronchitis receiving almitrine or placebo.
    Allen MB; Prowse K
    Thorax; 1989 Apr; 44(4):292-7. PubMed ID: 2548299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Almitrine in chronic airflow obstruction.
    Lancet; 1985 Apr; 1(8432):796-7. PubMed ID: 2858674
    [No Abstract]   [Full Text] [Related]  

  • 48. [An improvement in the hypoxemia after almitrine treatment in patients with chronic obstructive pulmonary diseases].
    Marcos Sánchez F; Celdrán Gil J; Santurino Martín JA; Hernández Lanchas C; Durán Pérez-Navarro A
    Aten Primaria; 1993 Nov; 12(9):628-9. PubMed ID: 8298000
    [No Abstract]   [Full Text] [Related]  

  • 49. Peripheral neuropathy in patients treated with almitrine dimesylate.
    Gherardi R; Louarn F; Benvenuti C; Perrier M; Lejonc JL; Schaeffer A; Degos JD
    Lancet; 1985 Jun; 1(8440):1247-50. PubMed ID: 2860446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peripheral neuropathy during treatment with almitrine.
    Chedru F; Nodzenski R; Dunand JF; Amarenco G; Ghnassia R; Ciaudo-Lacroix C; Said G
    Br Med J (Clin Res Ed); 1985 Mar; 290(6472):896. PubMed ID: 2983821
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-term effects and safety of almitrine-raubasine in age-associated cognitive decline.
    Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S109-16. PubMed ID: 2093415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Memory disorders in 8,037 elderly patients with age-associated memory impairment: multicenter trial with a 6-month follow-up under almitrine-raubasine.
    Poitrenaud J; Laurent B; Sebban C
    Eur Neurol; 1995; 35 Suppl 1():43-6. PubMed ID: 8529729
    [No Abstract]   [Full Text] [Related]  

  • 53. Almitrine-induced peripheral neuropathy and weight loss.
    Gherardi R; Bélec L; Louarn F
    J Neurol; 1989 Sep; 236(6):374. PubMed ID: 2571682
    [No Abstract]   [Full Text] [Related]  

  • 54. [Sequential administration of a reduced dose of almitrine to patients with chronic obstructive bronchopneumopathies. A controlled multicenter study].
    Weitzenblum E; Arnaud F; Bignon J; Boutin C; Brune J; Castaing Y; Courty G; Derenne J; Duroux P; Fréour P
    Rev Mal Respir; 1992; 9(4):455-63. PubMed ID: 1509190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
    Voisin C; Howard P; Ansquer JC
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute and chronic effects of low dose almitrine bismesylate in the treatment of chronic bronchitis and emphysema.
    Winkelmann BR; Leinberger H; Hertrich FF; Rapp W; Dieterich HA; Ansquer JC
    Eur J Med; 1992 Dec; 1(8):469-81. PubMed ID: 1341206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Almitrine in therapy of chronic obstructive respiratory tract diseases with hypoxemia--a clinical multicenter study comparing 2 dosages].
    Nowak D; Wywiol A; Magnussen H
    Pneumologie; 1998 Mar; 52(3):121-7. PubMed ID: 9564184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Almitrine: a peripheral respiratory stimulant in chronic obstructive pulmonary disease].
    Rubio Terrés C; López Alvarez M; Vargas Castrillón E
    Rev Clin Esp; 1990 Feb; 186(2):84-7. PubMed ID: 2158666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug therapy of sleep-related hypoxaemia.
    Weitzenblum E; Apprill M; Oswald M; Kurtz D
    Lung; 1990; 168 Suppl():948-54. PubMed ID: 2143553
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.